Latest News and Press Releases

TORONTO, June 13, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has today reported financial results of operations for the first quarter of fiscal 2009, ending April 30,...

TORONTO, April 30, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) has announced the results for its fiscal year ended January 31, 2008. All figures are reported in U.S....

TORONTO, Feb. 26, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that CONRAD, a lead investigator of Ushercell, has completed a clinical trial using rhesus monkeys....

TORONTO, Jan. 22, 2008 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announced today that on January 18, 2008, it received a Nasdaq Staff Deficiency Letter from The Nasdaq Stock...

TORONTO, Dec. 14, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports financial results for its third fiscal quarter, the three-month period ended October 31, 2007. ...

TORONTO, Dec. 3, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that CONRAD, a lead investigator of Ushercell, has commenced a Phase I trial to assess the safety of...

TORONTO, Oct. 1, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) today issued the following report on Company operations and objectives for the future. Cash and cash...

TORONTO, Sept. 17, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) announces that a final report has been received from Dr. Jose Simoes, the Principal Investigator in a Phase...

TORONTO, Sept. 14, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports on financial results of operations for the second quarter of fiscal 2008, ending July 31, 2007. ...

TORONTO, July 25, 2007 (PRIME NEWSWIRE) -- Polydex Pharmaceuticals Limited (Nasdaq:POLXF) reports that today at the International AIDS Society 2007 Conference in Sydney Australia, Dr. Lut Van Damme of...